Reducing alcohol intake alongside GLP-1 therapy may significantly improve outcomes for patients with obesity or diabetes risk.
David Shusterman, MD
Advertisement
Articles by David Shusterman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rocatinlimab Demonstrates Significant Efficacy and Safety in Phase 3 Trials for Moderate-to-Severe Atopic Dermatitis
2
Emerging Therapeutic Strategies Transforming Myelofibrosis Care in 2026
3
Circulating Extracellular Vesicles Contribute to Heart Failure Pathogenesis in CKD
4
What Pharmacists Should Know About Long COVID and Brain Health
5